2023
DOI: 10.1111/bjh.19012
|View full text |Cite
|
Sign up to set email alerts
|

Moving away from chemotherapy in newly diagnosed Philadelphia chromosome‐positive B‐cell acute lymphoblastic leukaemia

Abstract: Chemotherapy‐free regimens are reshaping the treatment landscape of Philadelphia chromosome‐positive acute lymphoblastic leukaemia. The report by Xie et al. suggests that the combination of dasatinib and prednisone is effective as induction and early consolidation. Survival was improved in patients who subsequently underwent allogeneic stem cell transplantation.Commentary on: Xie et al. Dasatinib plus prednisone as induction and consolidation for adults with Ph‐positive acute lymphoblastic leukaemia: A single‐… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…There is well documented evidence that age and performance score alone are not good predictors of frailty, and may not identify all patients at risk of adverse outcomes 4–9 . Several scores for assessing frailty have been developed and investigated in different branches of medicine 7–27 . Ferrara et al proposed definitions for lack of fitness for both intensive and non‐intensive chemotherapy 28 .…”
Section: Introductionmentioning
confidence: 99%
“…There is well documented evidence that age and performance score alone are not good predictors of frailty, and may not identify all patients at risk of adverse outcomes 4–9 . Several scores for assessing frailty have been developed and investigated in different branches of medicine 7–27 . Ferrara et al proposed definitions for lack of fitness for both intensive and non‐intensive chemotherapy 28 .…”
Section: Introductionmentioning
confidence: 99%